Journal of Atherosclerosis and Thrombosis
Online ISSN : 1880-3873
Print ISSN : 1340-3478
ISSN-L : 1340-3478
Original Article
Body Mass Index and Mortality from Nonrheumatic Aortic Valve Disease among Japanese Men and Women
Masayuki Teramoto, Kazumasa Yamagishi, Renzhe Cui, Kokoro Shirai, Akiko Tamakoshi, Hiroyasu Iso
著者情報
ジャーナル オープンアクセス HTML

2023 年 30 巻 2 号 p. 150-159

詳細
抄録

Aim: We aimed to examine the impact of overweight and obesity on mortality from nonrheumatic aortic valve disease.

Methods: In the Japan Collaborative Cohort Study, we analyzed data of 98,378 participants aged 40–79 years, with no history of coronary heart disease, stroke, or cancer at baseline (1988–1990) and who completed a lifestyle questionnaire including height and body weight; they were followed for mortality until the end of 2009. The Cox proportional hazards model was used to calculate the multivariable hazard ratios (HRs) with 95% confidence intervals (CIs) of nonrheumatic aortic valve disease mortality according to body mass index (BMI) after adjusting for potential confounding factors.

Results: During the median 19.2 years follow-up, 60 deaths from nonrheumatic aortic valve disease were reported. BMI was positively associated with the risk of mortality from nonrheumatic aortic valve disease; the multivariable HRs (95% CIs) were 0.90 (0.40–2.06) for persons with BMI <21 kg/m2, 1.71 (0.81–3.58) for BMI 23–24.9 kg/m2, 1.65 (0.69–3.94) for BMI 25–26.9 kg/m2, and 2.83 (1.20–6.65) for BMI ≥ 27 kg/m2 (p for trend=0.006), compared with persons with BMI 21–22.9 kg/m2. Similar associations were observed between men and women (p for interaction=0.56). Excluding those who died during the first ten years of follow-up or a competing risk analysis with other causes of death as competing risk events did not change the association materially.

Conclusions: Overweight and obesity may be independent risk factors for nonrheumatic aortic valve disease mortality in Asian populations.

著者関連情報

This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
https://creativecommons.org/licenses/by-nc-sa/4.0/
前の記事 次の記事
feedback
Top